NEWS
New Feature!!!! University Subject Rankings in 12 branches
FOR SCIENTIST REGISTRATION FOR INSTITUTIONAL BULK REGISTRATION
FOR EDIT YOUR UNIVERSITY / INSTITUTION PAGE
Some differences of the AD Scientific Index
New Feature!!!! University Subject Rankings in 12 branches
List without CERN, Statistical Data etc. Only in AD Scientific Index
New Feature!!!! University Subject Rankings in 12 branches
AD
Scientific Index 2024
About Us
Methodology
Compare & Choose
Contact - FAQ
login
Login
person_add
Register
school
University Rankings
subject
University Subject Rankings
place
Country Rankings
insights
i10 Productivity Rankings
insights
Subject Rankings
format_list_numbered
Top 100 Scientists
format_list_numbered
Citation Rankings
format_quote
Top 100 Institutions
local_fire_department
Country Top Lists
Linda Harrison
AD Scientific Index 2024
Medical and Health Sciences / Biostatistics
Harvard University - Cambridge / United States
Edit Form
Registration, Add Profile,
Premium Membership
Ranking &
Analysis
Job
Experiences (0)
Education
Information (0)
Published Books (0)
Book Chapters (0)
Articles (0)
Presentations (0)
Lessons (0)
Projects (0)
Congresses (0)
Editorship, Referee &
Scientific Board (0 )
Patents /
Designs (0)
Academic Grants
& Awards (0)
Artistic
Activities (0)
Certificate / Course
/ Trainings (0)
Association &
Society Memberships (0)
Contact, Office
& Social Media
person_outline
Linda Harrison's MOST POPULAR ARTICLES
1-)
Effect of HIV antibody VRC01 on viral rebound after treatment interruptionKJ Bar, MC Sneller, LJ Harrison, JS Justement, ET Overton, ME Petrone, ...New England Journal of Medicine 375 (21), 2037-2050, 20164002016
2-)
Tenofovir to Prevent Perinatal Transmission of Hepatitis B.G Jourdain, N Ngo-Giang-Huong, L Harrison, iTAP Study GroupThe New England journal of medicine 378 (24), 2350, 20182492018
3-)
Tenofovir versus placebo to prevent perinatal transmission of hepatitis BG Jourdain, N Ngo-Giang-Huong, L Harrison, L Decker, W Khamduang, ...New England Journal of Medicine, 20182472018
4-)
Effect of HIV-1 subtype on virologic and immunologic response to starting highly active antiretroviral therapyAM Geretti, L Harrison, H Green, C Sabin, T Hill, E Fearnhill, D Pillay, ...Clinical infectious diseases 48 (9), 1296-1305, 20091972009
5-)
First-line antiretroviral therapy with a protease inhibitor versus non-nucleoside reverse transcriptase inhibitor and switch at higher versus low viral load in HIV-infected …PENPACT-1 (PENTA 9/PACTG 390) Study TeamThe Lancet infectious diseases 11 (4), 273-283, 2011142*2011
ARTICLES
Add your articles
We use cookies to personalize our website and offer you a better experience. If you accept cookies, we can offer you special services.
Cookie Policy
Accept